Viewing Study NCT05810350


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2025-12-26 @ 8:10 PM
Study NCT ID: NCT05810350
Status: UNKNOWN
Last Update Posted: 2023-04-13
First Post: 2023-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Sponsor: Three Gorges Hospital of Chongqing University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module